CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO)

15 filings reported holding CERO - CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share as of Q1 2024.
CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.52M shares of 5.17M outstanding shares and own 29.31% of the company stock.
Largest 10 shareholders include ARCH Venture Management, LLC (1.44M shares), JANE STREET GROUP, LLC (26.5K shares), Birchview Capital, LP (13K shares), GEODE CAPITAL MANAGEMENT, LLC (10.6K shares), FNY Investment Advisers, LLC (10.5K shares), KESTRA PRIVATE WEALTH SERVICES, LLC (10K shares), Pineridge Advisors LLC (300 shares), JPMORGAN CHASE & CO (2 shares), CLEAR STREET LLC (0 shares), and Yakira Capital Management, Inc. (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.